CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 56 filers reported holding CABALETTA BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $319,057 | +23.6% | 20,963 | +4.8% | 0.00% | – |
| Q2 2023 | $258,200 | -42.9% | 20,000 | -63.4% | 0.00% | – |
| Q1 2023 | $452,344 | -57.5% | 54,697 | -52.4% | 0.00% | – |
| Q4 2022 | $1,063,547 | +1511.4% | 114,978 | +13.7% | 0.00% | – |
| Q3 2022 | $66,000 | -95.0% | 101,100 | -91.9% | 0.00% | – |
| Q2 2022 | $1,330,000 | -55.6% | 1,254,479 | -15.0% | 0.00% | -100.0% |
| Q1 2022 | $2,994,000 | -49.5% | 1,475,100 | -5.7% | 0.00% | 0.0% |
| Q4 2021 | $5,925,000 | -20.9% | 1,563,523 | +153.8% | 0.00% | 0.0% |
| Q3 2021 | $7,490,000 | +1218.7% | 615,967 | +832.8% | 0.00% | – |
| Q2 2021 | $568,000 | +171.8% | 66,032 | +250.3% | 0.00% | – |
| Q1 2021 | $209,000 | +54.8% | 18,851 | +74.4% | 0.00% | – |
| Q4 2020 | $135,000 | +13.4% | 10,809 | -33.7% | 0.00% | – |
| Q1 2020 | $119,000 | – | 16,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 2,064,263 | $4,190,000 | 0.92% |
| Kynam Capital Management, LP | 616,125 | $1,251,000 | 0.41% |
| Ikarian Capital, LLC | 1,020,070 | $2,070,000 | 0.27% |
| Cormorant Asset Management, LP | 1,154,424 | $2,343,000 | 0.18% |
| Ikarian Capital, LLC | 449,000 | $912,000 | 0.12% |
| HARBOR CAPITAL ADVISORS, INC. | 119,315 | $242,000 | 0.11% |
| Boxer Capital, LLC | 540,000 | $1,096,000 | 0.06% |
| SAMLYN CAPITAL, LLC | 1,768,083 | $3,589,000 | 0.05% |
| Redmile Group, LLC | 696,377 | $1,414,000 | 0.04% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 464,252 | $942,000 | 0.02% |